Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
1.080
+0.030 (2.86%)
At close: May 12, 2025, 4:00 PM
1.040
-0.040 (-3.70%)
After-hours: May 12, 2025, 7:58 PM EDT
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $15.12 million as of May 12, 2025. Its market cap has increased by 55.88% in one year.
Market Cap
15.12M
Enterprise Value
11.32M
1-Year Change
55.88%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $15.12M, a decrease of -78.61%. That is a compound annual growth rate of -15.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 14.70M | 188.24% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |